Short stature due to growth hormone qualitative anomaly (Q106510): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Esta síndrome é caracterizada por retardo do crescimento e baixa estatura (apesar da presença de níveis normais ou ligeiramente elevados de hormônio do crescimento imunorreativo, GH), baixas concentrações do fator de crescimento semelhante a insulina-1 (IGF-1) e um aumento significativo da taxa de crescimento após terapia com GH recombinante. A prevalência é desconhecida mas apenas poucos casos já foram relatados na literatura. A síndrome é causada por várias mutações no gene GH1 (17q22-q24) que resultam em anormalidades estruturais no GH e uma molécula biologicamente inativa. A transmissão é autossômica recessiva. | |||
| description / en | description / en | ||
This syndrome is characterised by growth retardation and short stature (despite the presence of normal or slightly elevated levels of immunoreactive growth hormone, GH), low concentrations of insulin-like growth factor-I (IGF-I) and a significant increase in growth rate following recombinant GH therapy. Prevalence is unknown but only a few cases have been reported in the literature. The syndrome is caused by various mutations in the GH1 gene (17q22-q24) that result in structural GH anomalies and a biologically inactive molecule. Transmission is autosomal recessive. | |||
Revision as of 13:29, 17 August 2026
This syndrome is characterised by growth retardation and short stature (despite the presence of normal or slightly elevated levels of immunoreactive growth hormone, GH), low concentrations of insulin-like growth factor-I (IGF-I) and a significant increase in growth rate following recombinant GH therapy. Prevalence is unknown but only a few cases have been reported in the literature. The syndrome is caused by various mutations in the GH1 gene (17q22-q24) that result in structural GH anomalies and a biologically inactive molecule. Transmission is autosomal recessive.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1665498704 |
||
| English | Short stature due to growth hormone qualitative anomaly |
This syndrome is characterised by growth retardation and short stature (despite the presence of normal or slightly elevated levels of immunoreactive growth hormone, GH), low concentrations of insulin-like growth factor-I (IGF-I) and a significant increase in growth rate following recombinant GH therapy. Prevalence is unknown but only a few cases have been reported in the literature. The syndrome is caused by various mutations in the GH1 gene (17q22-q24) that result in structural GH anomalies and a biologically inactive molecule. Transmission is autosomal recessive. |
